Global Biodefense Market to Reach US$ 28.0 Billion by 2032, Stimulated by Rising Threat of Bioterrorism

May 31, 2023 | Healthcare

According to the latest report by IMARC Group, titled "Biodefense Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032," the global biodefense market size reached US$ 16.8 Billion in 2023. The term biodefense refers to a broad range of precautions and tactics implemented to safeguard people against the intentional or unintentional release of biological agents that might hurt or endanger the environment, agriculture, or public health. It includes a variety of initiatives meant to stop, identify, and address biological hazards, such as naturally occurring infectious illnesses, bioterrorism occurrences, and outbreaks of newly or re-emerging diseases. Its main objective is to protect human and animal health by reducing the negative effects that biological threats have on individuals, entire communities, and society as a whole. This multidisciplinary field brings together the efforts of public health organizations, medical specialists, researchers, academics, law enforcement, first responders, intelligence agencies, and several other stakeholders to build a resilient and effective defense system.

Global Biodefense Market Trends:

The escalating demand for biological weapons majorly drives the global market. This can be supported by the rising concerns about the deliberate release of pathogens, the potential for widespread outbreaks, and the persistent threat of bioterrorism. Along with this, the increasing occurrence of new and evolving infectious diseases, such as the coronavirus disease (COVID-19), is encouraging governments and numerous private organizations to heavily invest in biodefense to improve preparedness, surveillance, diagnostics, and a rapid response to these emerging infectious diseases, which is significantly supporting the market. Additionally, the growing funding activities to support research and development activities, the acquisition of advanced biodefense systems, and the establishment of robust infrastructure for surveillance and response are influencing the market favorably. In addition, the growing awareness regarding biodefense solutions, including personal protective equipment (PPE), vaccines, therapeutics, and surveillance systems, is propelling the market. Furthermore, continuous advancements in biotechnology, genomics, synthetic biology, and data analytics are creating a positive market outlook. Some of the other factors driving the market include increasing collaboration and partnerships and the rising importance of biosecurity. On account of the aforementioned factors, the market value is projected to reach US$ 28.0 Billion by 2032, expanding at a CAGR of 5.81% during 2024-2032.

Market Summary:

  • On the basis of the vaccine type, the market has been divided into anthrax, smallpox, botulism, and others.
  • Based on the biothreat detection device, the market has been segmented into samplers, detectors/triggering devices, identifiers, assays, and others.
  • On the basis of the end-user, the market has been divided into hospitals and clinics, ambulatory care centers, and others.
  • Region-wise, the market has been segmented into North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.
  • The competitive landscape of the market has been studied in the report with the detailed profiles of the key players. Some of these players include Achaogen Inc., Alnylam Pharmaceuticals Inc., Altimmune Inc. (PharmAthene Inc.), Bavarian Nordic A/S, Cleveland BioLabs Inc., Dynavax Technologies Corporation, Dynport Vaccine Company LLC (General Dynamics Corporation), Elusys Therapeutics Inc., Emergent Biosolutions Inc., Ichor Medical Systems Inc., Ology Bioservices Inc., and SIGA Technologies, Inc.

Report Scope:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Vaccine Type, Biothreat Detection Device, End-User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Achaogen Inc., Alnylam Pharmaceuticals Inc., Altimmune Inc. (PharmAthene Inc.), Bavarian Nordic A/S, Cleveland BioLabs Inc., Dynavax Technologies Corporation, Dynport Vaccine Company LLC (General Dynamics Corporation), Elusys Therapeutics Inc., Emergent Biosolutions Inc., Ichor Medical Systems Inc., Ology Bioservices Inc. and SIGA Technologies, Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Biodefense Market to Reach US$ 28.0 Billion by 2032, Stimulated by Rising Threat of Bioterrorism
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-713-2163


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More